Black Seed (Nigella Sativa) for Blood Pressure Regulation

Research suggests that black seed (Nigella sativa) and its primary active compound thymoquinone (TQ) may influence blood pressure regulation through several proposed biological mechanisms, including inhibition of angiotensin-converting enzyme (ACE), modulation of the sodium-potassium pump via oleic and linoleic acids, and reduction of oxidative stress and inflammation in tissues relevant to cardiovascular function. Studies indicate that most of the available evidence comes from laboratory experiments, animal studies, and broad narrative reviews rather than rigorous human clinical trials, which limits how directly these findings can be applied to people. One rat study found that TQ reduced blood pressure elevations associated with antipsychotic medication use, and in vitro work identified fatty acids from black seed oil as capable of inhibiting ACE activity, though one isolated fraction was found to increase ACE activity, introducing a note of complexity to the otherwise supportive picture. Overall, while the mechanistic and preclinical findings are promising and point to plausible pathways, well-designed human trials are still needed before firm conclusions can be drawn about black seed's effectiveness for blood pressure regulation in people.